Chugai Pharmaceutical researchers awarded Lasker-DeBakey Clinical Medical Research Award
Story essentials
Dr. Kunihiro Hattori, Dr. Takehisa Kitazawa, Dr. Tomoyuki Igawa (Chugai Pharmaceutical)
New York, USA
September 9, 2026
This page is produced by collecting and structuring multiple public reports. Sections based only on reporting or testimony affect the displayed assessment, and the page is updated when new information is identified.
About this article
COMPAMIR Editorial Team
The COMPAMIR editorial team brings together public reporting and links to the original coverage. We update the page as new information emerges.
Read our editorial policy- Earlier version 19/9/2026, 3:40:40 PM
Three Chugai researchers recognized for the invention of Hemlibra (emicizumab). Hemlibra is a bispecific antibody for hemophilia A treatment. Marks the second time Japanese researchers have received this award in the clinical category.
Read next
Prioritized by shared people, places, and events.
US stock markets open lower amid Middle East tensions
US stock indexes opened lower on Sep 9. Oil prices surged past $100 a barrel due to Middle East tensions. Dow, S&P 500, and Nasdaq all saw declines at the open.